Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4L454 | — |
Kinrix was given to patient outside of age range; This non-serious case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. On 19-JAN-2026, the patient received Kinrix. On 19-JAN-2026, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix was given to patient outside of age range). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 21-JAN-2026 No side effects reported.